ALPINE IMMUNE SCIENCES, INC.

Pharmaceutical Preparations·SEATTLE, WA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q1 2024	3/31/24	5/9/24	→
10-K/A	FY 2023	12/31/23	4/26/24	→
10-K	FY 2023	12/31/23	3/20/24	→
10-Q	Q3 2023	9/30/23	11/14/23	→
10-Q	Q2 2023	6/30/23	8/14/23	→
10-Q	Q1 2023	3/31/23	5/11/23	→
↓

Earnings Releases (8-K)

29 shown

Filed	Period
5/9/24	Q2 FY2024	→
3/18/24	Q1 FY2024	→
11/14/23	Q4 FY2023	→
11/6/23	Q4 FY2023	→
8/14/23	Q3 FY2023	→
5/11/23	Q2 FY2023	→
↓

News (8-K)

51 shown

Filed	Type	Description
5/20/24	Delisting	Termination of a Material Definitive Agreement	→
4/10/24	Agreement	Entry into a Material Definitive Agreement	→
4/5/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/7/24	Other	Unregistered Sales of Equity Securities	→
1/5/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/21/23	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
5/20/24	S-8 POS	S-8 POS	→
5/20/24	S-8 POS	S-8 POS	→
5/20/24	S-8 POS	S-8 POS	→
5/20/24	S-8 POS	S-8 POS	→
5/20/24	S-8 POS	S-8 POS	→
5/20/24	S-8 POS	S-8 POS	→
↓

Filing History(646 filings)

TypeDateAccessionPeriodSize

SC 13G/A

Nov 14, 2024

0001172661-24-005283

—

106.9 KB

15-12G

May 30, 2024

0001193125-24-14992115-12G

—

11.2 KB

EFFECT

May 23, 2024

9999999995-24-001632

—

1.9 KB

EFFECT

May 23, 2024

9999999995-24-001631

—

1.9 KB

SC 13D/A

May 21, 2024

0001104659-24-063883SC 13D/A

—

79.5 KB

SC 13D/A

May 21, 2024

0001193125-24-143527SC 13D/A

—

173.0 KB

May 20, 2024

0001626199-24-000101FORM 4

May 20, 2024

22.1 KB

May 20, 2024

0001626199-24-000100FORM 4

May 20, 2024

16.8 KB

May 20, 2024

0001626199-24-000099FORM 4

May 20, 2024

12.8 KB

May 20, 2024

0001626199-24-000098FORM 4

May 20, 2024

28.3 KB

May 20, 2024

0001626199-24-000097FORM 4

May 18, 2024

22.5 KB

May 20, 2024

0001626199-24-000096FORM 4

May 18, 2024

26.1 KB

May 20, 2024

0001626199-24-000095FORM 4

May 18, 2024

29.3 KB

May 20, 2024

0001626199-24-000094FORM 4

May 20, 2024

27.7 KB

May 20, 2024

0001626199-24-000093FORM 4

May 20, 2024

29.8 KB

May 20, 2024

0001626199-24-000092FORM 4

May 18, 2024

32.3 KB

May 20, 2024

0001626199-24-000091FORM 4

May 20, 2024

17.0 KB

May 20, 2024

0001626199-24-000090FORM 4

May 20, 2024

23.6 KB

May 20, 2024

0000947871-24-000504

May 18, 2024

13.9 KB

25-NSE

May 20, 2024

0001354457-24-000354

—

3.1 KB

S-8 POS

May 20, 2024

0001193125-24-142315S-8 POS

—

39.2 KB

S-8 POS

May 20, 2024

0001193125-24-142314S-8 POS

—

39.2 KB

S-8 POS

May 20, 2024

0001193125-24-142313S-8 POS

—

39.2 KB

S-8 POS

May 20, 2024

0001193125-24-142311S-8 POS

—

39.2 KB

S-8 POS

May 20, 2024

0001193125-24-142310S-8 POS

—

39.2 KB

25 filings shown

Filed	Form	Description
4/27/23	DEFA14A	DEFA14A	→
4/27/23	DEF 14A	DEF 14A	→
4/14/23	PRE 14A	PRE 14A	→
4/29/22	DEFA14A	DEFA14A	→
4/29/22	DEF 14A	DEF 14A	→
4/29/21	DEFA14A	DEFA14A	→
↓

ALPINE IMMUNE SCIENCES, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(646 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
5/21/24	SC 13D/A	SC 13D/A	→
5/21/24	SC 13D/A	SC 13D/A	→
5/20/24	4	4	→
5/20/24	4	4	→
5/20/24	4	4	→
↓

Filed	Form	Description
5/30/24	15-12G	15-12G	→
5/23/24	EFFECT	EFFECT	→
5/23/24	EFFECT	EFFECT	→
5/20/24	25-NSE	25-NSE	→
5/20/24	POS AM	POS AM	→
5/20/24	POS AM	POS AM	→
↓